About Esperante

Esperante is a corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe. Esperante is part of C&P Investors Group, a pharmaceutical group of companies engaged in the development, manufacturing, marketing and sales of diagnostic, ophthalmic, pharmaceutical and peptide-based products and services.

Therapeutic fields of interest

Endocrinology
Hepatology
Ophthalmology
Gastroenterology
Infectious disease
Otology
Gynaecology
Oncology
Urology

Our portfolio

Our portfolio companies are active in the clinical and regulatory phases of development, in pharmaceutical therapeutics and in-vitro diagnostics and the majority are based in Europe and North America. Current therapeutic fields include dermatology, hepatology, infectious disease, oncology and urology.

Acousia Therapeutics
Altimmune
AMLo Biosciences
Cara Therapeutics
Cytox
Kiyatec
Lumira Dx
Medicenna Therapeutics
Momentum Biosciences
Oxford Cancer Biomarkers

Our latest news